GB201520862D0 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- GB201520862D0 GB201520862D0 GBGB1520862.2A GB201520862A GB201520862D0 GB 201520862 D0 GB201520862 D0 GB 201520862D0 GB 201520862 A GB201520862 A GB 201520862A GB 201520862 D0 GB201520862 D0 GB 201520862D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1520862.2A GB201520862D0 (en) | 2015-11-25 | 2015-11-25 | Pharmaceutical composition |
| PCT/EP2016/078564 WO2017089404A1 (en) | 2015-11-25 | 2016-11-23 | Pharmaceutical composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1520862.2A GB201520862D0 (en) | 2015-11-25 | 2015-11-25 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201520862D0 true GB201520862D0 (en) | 2016-01-13 |
Family
ID=55177258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1520862.2A Ceased GB201520862D0 (en) | 2015-11-25 | 2015-11-25 | Pharmaceutical composition |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201520862D0 (en) |
| WO (1) | WO2017089404A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA122811C2 (en) * | 2018-08-10 | 2021-01-06 | Наталія Миколаївна Тихонівська | PHARMACEUTICAL COMPOSITION |
| WO2020084549A1 (en) * | 2018-10-25 | 2020-04-30 | Glenmark Specialty S.A. | Nebulization composition comprising glycopyrrolate and formoterol |
| BR112023001689A2 (en) * | 2020-07-31 | 2023-05-02 | Chemo Res S L | COMBINATION THERAPY FOR INHALATION ADMINISTRATION |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013203244B2 (en) * | 2009-10-16 | 2016-11-03 | Jagotec Ag | Improved formulations |
| JP2014505717A (en) * | 2011-02-17 | 2014-03-06 | シプラ・リミテッド | Pharmaceutical composition |
| AU2014210942A1 (en) * | 2013-01-31 | 2015-08-20 | Prosonix Limited | Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy |
| PL3096737T3 (en) * | 2013-12-30 | 2018-08-31 | Chiesi Farmaceutici S.P.A. | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
-
2015
- 2015-11-25 GB GBGB1520862.2A patent/GB201520862D0/en not_active Ceased
-
2016
- 2016-11-23 WO PCT/EP2016/078564 patent/WO2017089404A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017089404A1 (en) | 2017-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL265260B (en) | Pharmaceutical composition | |
| IL265360A (en) | Pharmaceutical composition | |
| IL262654A (en) | Pharmaceutical composition | |
| GB201409471D0 (en) | Pharmaceutical composition | |
| GB201409488D0 (en) | Pharmaceutical composition | |
| IL265349A (en) | Pharmaceutical composition | |
| GB201409485D0 (en) | Pharmaceutical composition | |
| HUE046729T2 (en) | Pharmaceutical composition containing mirabegron | |
| GB201521462D0 (en) | Pharmaceutical composition | |
| GB201506526D0 (en) | Medicinal composition | |
| IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
| ZA201502073B (en) | Pharmaceutical composition | |
| PL3454838T3 (en) | Pharmaceutical composition | |
| GB201615917D0 (en) | Pharmaceutical composition | |
| GB201515310D0 (en) | Pharmaceutical composition | |
| ZA201508726B (en) | Pharmaceutical composition | |
| IL255510A (en) | Pharmaceutical compositions | |
| GB201615914D0 (en) | Pharmaceutical composition | |
| GB201520862D0 (en) | Pharmaceutical composition | |
| SMT202000391T1 (en) | Pharmaceutical composition | |
| GB201615910D0 (en) | Pharmaceutical composition | |
| SG10201504332VA (en) | Pharmaceutical Composition | |
| IL265436B (en) | Pharmaceutical composition | |
| PL3424500T3 (en) | Pharmaceutical composition comprising famitinib | |
| GB201620519D0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |